Ebopiprant Uses, Dosage, Side Effects and more
Ebopiprant is under investigation in clinical trial NCT03369262 (Poc Study of OBE022 in Threatened Preterm Labour).
| Attribute | Details |
|---|---|
| Trade Name | Ebopiprant |
| Generic | Ebopiprant |
| Ebopiprant Other Names | Ebopiprant |
| Type | |
| Formula | C30H34FN3O5S2 |
| Weight | Average: 599.74 Monoisotopic: 599.192391718 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
